| Terlinden A, Ethgen O, Curran D, Demarteau N. Potential risk-sharing agreements for vaccines. To be presented at the 17th European Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) – Amsterdam, The Netherlands, November 8-12th, 2014. |
| Bagshaw S, Ethgen O, Schneider A, Bellomo R, Kellum J. Continuous or intermittent renal replacement therapy in Acute kidney injury: An economic perspective. Critical Care Congress – San Francisco, USA, January 9-13th, 2014. Critical Care Medicine 2013;41:A254-A255. |
| Ethgen O, Schneider AG, Bagshaw SM, Bellomo R, Kellum JA. Economics of dialysis dependence following acute kidney injury (AKI) in the intensive care unit (ICU). 16th European Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) – Dublin, Ireland, November 2-6th, 2013. Value in Health 2013;16:A631. |
| Standaert B, Ethgen O, Emerson R, Postma M. An analysis of how not to use cost-effectiveness analysis for price-setting. 16th European Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) – Dublin, Ireland, November 2-6th, 2013. Value in Health 2013;16:A616. |
| Ethgen O. The value of personalized medicine: It is more about unveiling the performance of the companion diagnostic. 15th European Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) – Berlin, Germany, November 3-7th, 2012. Value in Health 2012;15:A492. |
| Ethgen O, Topachevskyi O, Connolly M, Standaert B. Optimizing public health decision over time: A dynamic budget optimization model with multiple criteria decision making. 15th European Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) – Berlin, Germany, November 3-7th, 2012. Value in Health 2012;15:A491. |
| Ethgen O. One day money will only be spent on effective drugs…From payers’ aspirations to performance-based risk-sharing operations. 17th International Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) – Washington DC, USA, June 2-6th, 2012. Value in Health 2012;15:A164. |
| Hutchings A, Ethgen O, Schmidt C, Rollet P. Defining elements of value for rare disease treatments. 17th International Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) – Washington DC, USA, June 2-6th, 2012. Value in Health 2012;15:A31. |
| Ethgen O, Hutchings A, Rollet P, Standaert B. From value to price: What should be the path for orphan drugs? 17th International Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) – Washington DC, USA, June 2-6th, 2012. Value in Health 2012;15:A31. |
| Bruyere O, Vanoverberghe M, Neuprez A, Ethgen O, Zegels B, Gillet P, Huskin JP, Reginster JY. Health-related quality of life after total knee or hip replacement: A 7-year prospective study. 10th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO) – Florence, Italy, May 5-8th, 2010. Osteoporosis International 2010; 21 Suppl.1:S26. |
| Ethgen O, Hiligsmann M, Reginster JY. Modelling the uptake and diffusion of innovative technology: A critical and strategic feature of budget impact analysis and risk-sharing agreements. 12th European Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) – Paris, France, October 24-27th, 2009. Value in Health 2009;12:A395. |
| Ethgen O, Koncz T. Modelling the Sustainability of the DAS28 Reduction with Abatacept versus Rituximab for Rheumatoid Arthritis Patients with an Inadequate Response to Anti-TNF Therapy. Annual European Congress of Rheumatology – European Ligue Against Rheumatism (EULAR) – Paris, France, June 11-14th, 2008. Annals of the Rheumatic Diseases 2008; 67 Suppl.II:191. |
| Lescrauwaet B, Lacante P, Ethgen O. Selecting an appropriate comparator for the budget impact analysis of abatacept in the treatment of rheumatoid arthritis: the Belgian case. Annual European Congress of Rheumatology – European Ligue Against Rheumatism (EULAR) – Paris, France, June 11-14th, 2008. Annals of the Rheumatic Diseases 2008; 67 Suppl.II:609. |
| Pedro S, Ethgen O, Ramiro S, Marques R, Michaud K, Wolfe F, Benito-Garcia E. Direct and indirect costs and their predictors in patients with rheumatoid arthritis in Portugal. Annual European Congress of Rheumatology – European Ligue Against Rheumatism (EULAR) – Paris, France, June 11-14th, 2008. Annals of the Rheumatic Diseases 2008; 67 Suppl.II:574. |
| Borgström F, Arnetorp S, Ethgen O, Kutikova L, Fisher M. Economic evaluation of abatacept for the treatment of rheumatoid arthritis in Austria. Annual European Congress of Rheumatology – European Ligue Against Rheumatism (EULAR) – Paris, France, June 11-14th, 2008. Annals of the Rheumatic Diseases 2008; 67 Suppl.II:608. |
| Hiligsmann M, Bruyère O, Ethgen O, Reginster JY. Efficiency of calcium and vitamin D in the management of osteoporosis. 8th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO) – Istanbul, Turkey, April 9-12th, 2008. Osteoporosis International 2008; 19 Suppl.1:S113-4. |
| Hiligsmann M, Bruyère O, Ethgen O, Pire G, Reginster JY. Efficiency and recommendations for osteoporosis screening strategy. 8th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO) – Istanbul, Turkey, April 9-12th, 2008. Osteoporosis International 2008; 19 Suppl.1:S116-7. |
| Hiligsmann M, Bruyère O, Ethgen O, Reginster JY. Cost-effectiveness of mass screening and targeted biphosphonates treatment in osteoporosis. 8th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO) – Istanbul, Turkey, April 9-12th, 2008. Osteoporosis International 2008; 19 Suppl.1:S117. |
| Hiligsmann M, Bruyère O, Ethgen O, Reginster JY. Cost-effectiveness of osteoporosis screening campaign for Belgian women. 10th European Congress of the International Society of Pharmacoeconomics and Outcome Research (ISPOR) – Dublin, Ireland, October 20th-23rd, 2007. Value in Health 2007;10:A395. |
| Hiligsmann M, Richy F, Ethgen O, Bruyère O, Reginster JY. Rationale and development of an individual patient-based model to accurately assess the efficacy of osteoporosis management. 7th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO) – Porto, Portugal, March 30th-31st, 2007. Osteoporosis International 2007; 18 Suppl.1:xx. |
| Ethgen O, Spaepen E, Moeremans K, Annemans L. Economic impact of hospital malnutrition. 8th European Congress of the International Society of Pharmacoeconomics and Outcome Research (ISPOR) – Florence, Italy, November 6-8th, 2005. Value in Health 2005;88:A68-9. |
| Ethgen O, Yang XL, Spaepen E, Annemans L. Everolimus with reduced-dose cyclosporine vs. mycophenolate motefil with full-dose cyclosporine: An European health economic perspective in de novo renal transplant recipients. 12th European Society for Organ Transplantation (ESOT) – Geneva, Switzerland, October 15-19th, 2005. Transplant International 2005;18:106. |
| Ethgen O, Keown P, Yang XL, Ricci JF, Spaepen E, Annemans L. Economic evaluation of everolimus with reduced-dose cyclosporine in de novo renal transplantation recipients: an international perspective. 10th Congress of the International Society of Pharmacoeconomics and Outcome Research (ISPOR) – Washington DC, USA, May 15-18th, 2005. Value in Health 2005;8:414. |
| Keown P, Ethgen O, yang XL, Ricci JF, Kessabi S, Spaepen E, Annemans L. Economic evaluation of everolimus with reduced-dose cyclosporine in de novo renal transplantation recipients. 2005 American Transplant Congress (ATC) Meeting – Seattle, WA, USA, May 21st-25th, 2005. American Journal of Transplantation 2005;5 (Suppl.11):504. |
| Ethgen O, Richy F, Cools P, Devillers J, Reginster JY. Health-related quality of life as a predictor of direct costs in osteoarthritis. 5th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO) – Roma, Italy, March 16-19th, 2005. Osteoporosis International 2005;16 Suppl.3:S59. |
| Ethgen O, Gillain D, Gillet P, Gosset C, Jousten A, Reginster JY. Age- and sex-stratified prevalence of physical disabilities and handicap in the general population. 5th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO) – Roma, Italy, March 16-19th, 2005. Osteoporosis International 2005;16 Suppl.3:S25. |
| Richy F, Schacht E, Bruyère O, Ethgen O, Gourlay M, Reginster JY. An indirect comparison of the efficacies of vitamin D and its hydroxylated analogs in postmenopausal and corticoid-induced osteoporosis. 5th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO) – Roma, Italy, March 16-19th, 2005. Osteoporosis International 2005;16 Suppl.3:S29. |
| Richy F, Gourlay M, Ross PD, Sen SS, Radican L, Ethgen O, Reginster JY. Risk assessment tools for osteoporosis: Scope and limits. 67th American College of Rheumatology (ACR) annual scientific meeting – Orlando, FL, USA, October 23rd-28th, 2003. Arthritis and Rheumatism 2003;48 Suppl.1:S215. |
| Richy F, Bruyère O, Ethgen O, Rabenda V, Bouvenot G, Audran M, Herrero-Beaumont G, Moore A, Eliakim R, Van De Putte L, Haim M, Reginster JY. Time-dependant risk of gastrointestinal complications induced by NSAIDs use: A consensus statement using meta-analytic approach. 4th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO) – Nice, France, November 14-17th, 2003. Osteoporosis International 2003;14 Suppl.7:S9. |
| Combescure C, Daures JP, Chevallier T, Ethgen O, Richy F, Viethel P, Reginster JY. Economic evaluation of OSIRIS® (Osteoporosis Index of Risk), a pre-screening tool for prediction of osteoporosis risk, using decision trees and Markov models. 4th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO) – Nice, France, November 14-17th, 2003. Osteoporosis International 2003;14 Suppl.7:S88. |
| Bruyère O, Wuidart MA, di Palma E, Gourlay M, Ethgen O, Richy F, JY Reginster. Controlled whole body vibration to decrease fall and improve health-related quality of life in elderly patients. 4th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO) – Nice, France, November 14-17th, 2003. Osteoporosis International 2003;14 Suppl.7:S63. |
| Ethgen O, Gosset C, Richy F, Reginster JY. Physical function is the most severely impaired health-related quality of life dimension during the aging process. 4th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO) – Nice, France, November 14-17th, 2003. Osteoporosis International 2003;14 Suppl.7:S65. |
| Ethgen O, Rabenda V, Bruyère O, Reginster JY. Projecting the prevalence of osteoarthritis and osteoporosis over the five forthcomings decades: Their increasing impact on public health. 4th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO) – Nice, France, November 14-17th, 2003. Osteoporosis International 2003;14 Suppl.7:S65-6. |
| Ethgen O, Tancredi A, Jacques J, Bruyère O, Richy F, Reginster JY. Do patients with osteoporotic hip fracture recover their initial health-related quality of life? 4th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO) – Nice, France, November 14-17th, 2003. Osteoporosis International 2003;14 Suppl.7:S66. |
| Ethgen O, Tancredi A, Brugneaux C, Richy F, Bruyère O, Reginster JY. Prospective evaluation of health-related quality of life in total hip and knee arthroplasties. 4th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO) – Nice, France, November 14-17th, 2003. Osteoporosis International 2003;14 Suppl.7:S66. |
| Richy F, Gourlay M, Neuprez A, Ethgen O, Bruyère O, Reginster JY. Bone mineral density and vertebral fractures in women who have discontinued hormone replacement therapy: A retrospective population-based study. 4th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO) – Nice, France, November 14-17th, 2003. Osteoporosis International 2003;14 Suppl.7:S67. |
| Richy F, Gourlay M, Ethgen O, Bruyère O, Reginster JY. Rationale to use OSIRIS® (Osteoporosis Index of Risk) to pre-screen for osteoporosis in the general oppualtion. 4th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO) – Nice, France, November 14-17th, 2003. Osteoporosis International 2003;14 Suppl.7:S67-8. |
| Rabenda V, Ethgen O, Belaiche J, Raeman F, Haim M, Reginster JY. Impact of osteoarthritis and chronic back pain on health related quality of life among patients on NSAIDs. 4th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO) – Nice, France, November 14-17th, 2003. Osteoporosis International 2003;14 Suppl.7:S89-90. |
| Ethgen O, Tancredi A, Lejeune E, Zegels B, Kvazs A, Reginster JY. Do willingness-to-pay and time trade-off approaches suitably reflect health outcomes in hip and knee osteoarthritis. 66th American College of Rheumatology (ACR) annual scientific meeting – New Orleans, LA, USA, October 25-29th, 2002. Arthritis and Rheumatism 2002;46 Suppl.1:S73. |
| Bruyère O, Colette J, Lejeune E, Richy F, Ethgen O, Seidel L; Henrotin Y, Reginster JY. Baseline measurement of urine pyridinoline and deoxypyridinoline is correlated with 3-year hip osteoarthritis progression. 66th American College of Rheumatology (ACR) annual scientific meeting – New Orleans, LA, USA, October 25-29th, 2002. Arthritis and Rheumatism 2002;46 Suppl.1:S149. |
| Bruyère O, Colette J, Lejeune E, Ethgen O, Richy F, Seidel L; Henrotin Y, Reginster JY. Correlation between biochemical markers of bone and cartilage metabolism and structural progression of hand osteoarthritis. 66th American College of Rheumatology (ACR) annual scientific meeting – New Orleans, LA, USA, October 25-29th, 2002. Arthritis and Rheumatism 2002;46 Suppl.1:S152. |
| Bruyère O, Ethgen O, Lejeune E, Giacovelli G, Richy F, seidel L, Henrotin Y, Rovati L, Reginster JY. Clinical severity of knee osteoarthritis poorly predicts long-term radiographic outcomes. 66th American College of Rheumatology (ACR) annual scientific meeting – New Orleans, LA, USA, October 25-29th, 2002. Arthritis and Rheumatism 2002;46 Suppl.1:S153. |
| Richy F, Bousquet J, Devogelaer JP, Ehrlich G, Meunier P, Peel N, Morii H, Ethgen O, Bruyère O, Reginster JY. Meta-analysis of the effects of inhaled corticosteroids on bone in asthmatic and COPD patients. 66th American College of Rheumatology (ACR) annual scientific meeting – New Orleans, LA, USA, October 25-29th, 2002. Arthritis and Rheumatism 2002;46 Suppl.1:S464. |
| Ethgen O, Bruyère O, Richy F, Paul I, Gosset C, Reginster JY. Health and economic burden of chronic osteoarticular disorders in the population aged over 45 years: A comparative analysis with other commonly reported chronic health dysfunctions. 66th American College of Rheumatology (ACR) annual scientific meeting – New Orleans, LA, USA, October 25-29th, 2002. Arthritis and Rheumatism 2002;46 Suppl.1:S469. |
| Richy F, Bousquet J, Devogelaer JP, Ehrlich G, Meunier P, Peel N, Morii H, Ethgen O, Bruyère O, Reginster JY. Inhaled corticosteroids effects on bone in asthmatic and COPD patients: what is the evidence? 3rd International Symposium on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis – Barcelona, Spain, November 6-9th, 2002. Osteoporosis International 2002;13 Suppl.3:S22. |
| Ethgen O, Tancredi A, Lejeune E, Zegels B, Kvazs A, Reginster JY. A comparative analysis between the time trade-off and the willingness to pay approaches in hip and knee osteoarthritis.3rd International Symposium on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis – Barcelona, Spain, November 6-9th, 2002. Osteoporosis International 2002;13 Suppl.3:S47. |
| Ethgen O, Richy F, De Ceulaer F, Bruyère O, Reginster JY. Musculoskeletal disorders in a time demographic changes: A real challenge for the future in Europe and Northern America. 3rd International Symposium on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis – Barcelona, Spain, November 6-9th, 2002. Osteoporosis International 2002;13 Suppl.3:S48. |
| Ethgen O, Bruyère O, Tancredi A, Richy F, De Ceulaer F, Reginster JY. Patient health profiles in osteoarthritis: is there a difference according to follow-up pattern? Results from the Belgian National Health Interview Survey. 3rd International Symposium on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis – Barcelona, Spain, November 6-9th, 2002. Osteoporosis International 2002;13 Suppl.3:S49. |
| Ethgen O, Richy F, Paul I, Gosset C, Reginster JY. Burden of chronic osteoatricular disorders compared to others commonly reported chronic conditions. Result from a large health interview survey of Belgian individuals aged over 45 years. 3rd International Symposium on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis – Barcelona, Spain, November 6-9th, 2002. Osteoporosis International 2002;13 Suppl.3:S49. |
| Ethgen O, Tellier V, Ben SedrineW, De Maeseneer J, Gosset C, Reginster JY. Health-related quality of life and cost of ambulatory care in osteoporosis. May such outcome measures be valuable information to health decision makers and payers? 5th Belgian congress on Rheumatology – Hasselt, Belgium, September 27-29th, 2001. Clinical Rheumatology 2001;20 (number 5):427. |
| Bruyère O, Ethgen O, Rovati L, Giacovelli G, Seidel L, Henrotin Y, Reginster JY. Radiographic severity of knee osteoarthritis is highly correlated with future progression of the disease. 6th Osteoarthritis Research Society International (OARSI) meeting – Washington, DC, USA, September 30th – October 3rd, 2001. Osteoarthritis and Cartilage 2001;9 Suppl B:S44. |
| Ethgen O, Vanparijs P, Delhalle S, Rosant S, Bruyère O, Reginster JY. Importance of social companionship in the determination of health-related quality of life in hip and knee osteoarthritis. 6th Osteoarthritis Research Society International (OARSI) meeting – Washington, DC, USA, September 30 – October 3, 2001.Osteoarthritis and Cartilage 2001, 9 Suppl B:S19 and 65th American College of Rheumatology (ACR) annual scientific meeting – San Francisco, CA, USA, November 10-15th, 2001. Arthritis and Rheumatism 2001;44 Suppl.1:S183. |
| Ben Sedrine W, Ethgen O, Devogelaer JP, Kaufman JM, Goemaere S, Depresseux G, Reginster JY. Toward an efficient strategy for osteoporosis screening: Diagnostic accuracy and cost-effectiveness of the proposals of the belgian social security institute. 65th American College of Rheumatology (ACR) annual scientific meeting – San Francisco, CA, USA, November 10-15th, 2001. Arthritis & Rheumatism 2001;44 Suppl.1:S319. |
| Ethgen O, Kahler KH, Kong SX, Reginster JY, Wolfe F. Health-related quality of life scores and future use of health care resources in patients with rheumatoid arthritis and osteoarthritis: implication for health services research in arthritis. Annual European Congress of Rheumatology – European Ligue Against Rheumatism (EULAR) – Nice, France, June 21st-24th, 2000. Annals of the Rheumatic Diseases 2000;59 Suppl 1:277. |
| Ben Sedrine W, Goemaere S, Depresseux G, Ethgen O, Devogelaer JP, Kaufman JM, Reginster JY. Validation of the criteria proposed by the Belgian social security institute for reimbursement of bone mineral density: A study in a sample of 4727 ambulatory subjects. 64th American College of Rheumatology (ACR) annual scientific meeting – Philadelphia, PN, USA, November 12-16th, 2000. Arthritis and Rheumatism 2000;43 Suppl.1:S142. |
| Ben Sedrine W, Goemaere S, Depresseux G, Ethgen O, Devogelaer JP, Kaufman JM, Reginster JY. The simple calculated osteoporosis risk estimation (SCORE) tool is more useful to reduce densitometry costs than for selecting patients with a high risk of osteoporosis. 64th American College of Rheumatology (ACR) annual scientific meeting – Philadelphia, PN, USA, November 12-16th, 2000. Arthritis and Rheumatism 2000;43 Suppl.1:S201. |
| Ethgen O, Ethgen D, Guillemin F, Reginster JY. Comparative analysis of healthcare use in patients with rheumatoid arthritis and control subject without chronic disease. International Federation of Societies for Skeletal Diseases – World Health Organization – European Foundation for Osteoporosis – Liège, Belgium, December 4-6th, 1997. Calcified Tissue International 1997;61: 499-512. |